# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001159036-25-000016
Filing Date
2025-03-18
Accepted
2025-03-18 16:10:39
Documents
28
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | halo-20250318.htm iXBRL | DEF 14A | 973081
6 | GRAPHIC | halo-20250318_g1.jpg | GRAPHIC | 38428
7 | GRAPHIC | halo-20250318_g10.jpg | GRAPHIC | 29136
8 | GRAPHIC | halo-20250318_g11.jpg | GRAPHIC | 169541
9 | GRAPHIC | halo-20250318_g12.jpg | GRAPHIC | 99578
10 | GRAPHIC | halo-20250318_g2.jpg | GRAPHIC | 31598
11 | GRAPHIC | halo-20250318_g3.jpg | GRAPHIC | 16244
12 | GRAPHIC | halo-20250318_g4.jpg | GRAPHIC | 47422
13 | GRAPHIC | halo-20250318_g5.jpg | GRAPHIC | 35581
14 | GRAPHIC | halo-20250318_g6.jpg | GRAPHIC | 36919
15 | GRAPHIC | halo-20250318_g7.jpg | GRAPHIC | 52580
16 | GRAPHIC | halo-20250318_g8.jpg | GRAPHIC | 32136
17 | GRAPHIC | halo-20250318_g9.jpg | GRAPHIC | 29734
| Complete submission text file | 0001159036-25-000016.txt |  | 3071237

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | halo-20250318.xsd | EX-101.SCH | 3670
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | halo-20250318_def.xml | EX-101.DEF | 4896
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | halo-20250318_lab.xml | EX-101.LAB | 6700
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | halo-20250318_pre.xml | EX-101.PRE | 3882
30 | EXTRACTED XBRL INSTANCE DOCUMENT | halo-20250318_htm.xml | XML | 92167

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32335 | Film No.: 25748384
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)